Organ Preservation Market by Product Type, Distribution Channel, End User 2024-2032


MARKETRESEARCH

Uploaded on Feb 29, 2024

According to the latest research report by IMARC Group, The global organ preservation market size reached US$ 187.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 313.4 Million by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. More Info:- https://www.imarcgroup.com/organ-preservation-market

Comments

                     

Organ Preservation Market by Product Type, Distribution Channel, End User 2024-2032

Global Organ Preservation Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . Accord ing to the l a t es t repor t by I MARC Group, t i t l ed " Organ Preservat i on Market : G l oba l Indust ry T rends , Share , S ize , Growth , O pportun i ty and Forecast 2024-2032 ," t he g loba l o rgan p reserva t ion marke t s i ze reached US$ 187 .9 M i l l i on in 2023. Report Organ p reserva t i on re fe rs t o t he m et hod o f conserv ing hea l thy o rgans to be fu r the r u t i l i zed fo r o rgan t ransp lan t a t ion . I t i s an essen t i a l t echn ique tha t he lps i n ma in t a in ing the f unc t ion ing o f t i s sues and o rgans so tha t t he g ra f t can func t i on a t Highlight and re -per fus ion . Some o f t he common p rese rva t ion techn iques i nc lude hypot he rm ic mach ine pe r f us ion , s ta t i c co ld s to rage , and normot hermic mach ine pe r f us ion . Description These met hods a id i n p rov id ing su f f i c ien t oxygen and nu t r i t i on tha t he lp i n reduc ing the chances o f pos t - t ransp lan t a t ion in fec t ions . A long w i th th i s , i t a l so a ids in improv ing t he su rv i va l r a tes and morb id i t y among pa t ien ts a f t e r t he t r ansp lan ta t ion . Request fo r a PDF sample o f th i s repor t : ht tps : / / www. imarcgroup .com/o rgan-prese rva t ion -marke t / reques tsamp le Report Description G lo b a l O r g a n P r e s e r v a t io n M a r k e t T r e n d s : T h e g l o b a l m a r k e t i s p r i m a r i l y d r i v e n b y t h e r i s i n g i n c i d e n c e s o f o r g a n f a i l u r e a m o n g t h e m a s s e s . T h i s i s s u p p o r t e d b y t h e i n c r e a s i n g p r e v a l e n c e o f c h r o n i c i l l n e s s e s a m o n g i n d i v i d u a l s , a l o n g w i t h t h e g r o w i n g g e r i a t r i c p o p u l a t i o n . M o r e o v e r , s i g n i f i c a n t i n v e s t m e n ts b y p r i v a t e a n d p u b l i c f i r m s t o u p g r a d e t h e e x i s t i n g h e a l t h c a r e i n f r a s t r u c t u r e i s f a v o r a b l y i m p a c t i n g t h e m a r k e t . I n l i n e w i t h t h i s , t h e w i d e s p r e a d u t i l i z a t i o n o f p r e s e r v a t i o n m e th o d s f o r c o n d u c t i n g e x p e r i m e n ta l s t u d i e s a n d c l i n i c a l t r i a l s i n m e d i c a l i n s t i t u t e s i s c r e a t i n g a p o s i t i v e m a r k e t o u t l o o k . A d d i t i o n a l l y , c o n t i n u o u s t e c h n o l o g i c a l a d v a n c e m e n ts i n o r g a n p r e s e r v a t i o n t e c h n i q u e s a r e a c t i n g a s m a j o r g r o w t h - i n d u c i n g f a c t o r s . F u r t h e r m o r e , n u m e r o u s i n i t i a t i v e s a r e u n d e r t a k e n b y g o v e r n m e n t a n d n o n - g o v e r n m e n t a l o r g a n i z a t i o n s ( N G O s ) o f m u l t i p l e c o u n t r i e s f o r e n c o u r a g i n g o r g a n d o n a t i o n a c t i v i t i e s a r e p r o v i d i n g a b o o s t t o t h e m a r k e t . O th e r f a c t o r s , i n c l u d i n g c o n t i n u a l i m p r o v e m e n ts i n t h e h e a l t h c a r e i n f r a s t r u c t u r e , t h e a c c e p t a n c e o f t r a n s p l a n t a t i o n p r o c e d u r e s , i n f l a t i n g d i s p o s a b l e i n c o m e l e v e l s o f t h e m a s s e s , a n d e x t e n s i v e r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a c t i v i t i e s c o n d u c t e d b y k e y p l a y e r s f o r i n t r o d u c i n g i m p r o v e d p r e s e r v a t i o n m e th o d s , a r e a l s o p o s i t i v e l y i n f l u e n c i n g t h e m a r k e t . L o o k in g f o r w a r d , t h e m a r k e t i s a n t i c i p a t e d t o r e a c h a v a lu e o f U S $ 3 1 3 . 4 M i l l i o n b y 2 0 3 2 , g r o w i n g a t a C A G R o f 5 . 7 % d u r i n g 2 0 2 4 - 2 0 3 2 . V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / o r g a n - p r e s e r v a t i o n - m a r k e t Breakup by Preservation Solution: • UW Solut ion • Custodiol HTK • Perfadex • Others   Breakup by Organ Donation Type: • Liv ing Organ Donation Report • Deceased Organ Donation Segmentation Breakup by Technique: • Stat ic Cold Storage Technique • Hypothermic Machine Perfus ion • Normothermic Machine Perfus ion • Others Breakup by Organ Type: • Kidney • Liver • Lung • Heart • Others Breakup by End-User: • Hospitals and Cl in ics Report • Organ Banks Segmentation • Others Breakup by Region: • North America • Asia-Pacifi c • Europe • Latin America • Middle East and Afr ica • 21st Century Medicine • Biol i fe Solutions • Bridge to Li fe Ltd. Competitive • Bristol -Myers Squibb • Dr. Franz Köhler Chemie GmbH Landscape • Essential Pharmaceuticals. with Key • Lifel ine Scientifi c Players • OrganOx • Paragonix Technologies • TransMedics • Waters Medical Systems • Xvivo Perfusion What was the size of the global organ preservation market in 2023? What is the expected growth rate of the global organ preservation market during 2024-2032? Key What are the key factors driving the global organ preservation market? Questions Answered in What has been the impact of COVID-19 on the global organ preservation market? the Report What is the breakup of the global organ preservation market based on the preservation solution? What is the breakup of the global organ preservation market based on the organ donation type? What is the breakup of the global organ preservation market based on the technique? What is the breakup of the global organ preservation market based on the organ type? What is the breakup of the global organ preservation market based on the end-user? Key What are the key regions in the global organ preservation market? Questions Answered in Who are the key players/companies in the global organ preservation market? the Report 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l O r g a n P r e s e r v a t i o n M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y P r e s e r v a t i o n S o l u t i o n 6 . 1 U W S o l u t i o n 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 C u s t o d i o l H T K 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 P e r f a d e x 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 O t h e r s 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y O r g a n D o n a t i o n T y p e 7 . 1 L i v i n g O r g a n D o n a t i o n 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 D e c e a s e d O r g a n D o n a t i o n 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t Table of 8 M a r k e t B r e a k u p b y T e c h n i q u e 8 . 1 S t a t i c C o l d S t o r a g e T e c h n i q u e 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t Contents 8 . 2 H y p o t h e r m i c M a c h i n e P e r f u s i o n 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 N o r m o t h e r m i c M a c h i n e P e r f u s i o n 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t 8 . 4 O t h e r s 8 . 4 . 1 M a r k e t T r e n d s 8 . 4 . 2 M a r k e t F o r e c a s t 9 M a r k e t B r e a k u p b y O r g a n T y p e 9 . 1 K i d n e y 9 . 1 . 1 M a r k e t T r e n d s 9 . 1 . 2 M a r k e t F o r e c a s t 9 . 2 L i v e r 9 . 2 . 1 M a r k e t T r e n d s 9 . 2 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : h t t p s : / / w w w. i m a rc g ro u p . c o m / o rg a n - p re s e r va t i o n - m a r ke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]